OriGene Technologies, Inc.
Left ProductsProducts divider ServicesServices divider technologyTechnology divider researchResearch divider TechsupportTechSupport divider AboutAbout Right

Your search returned 8 results.    Search:   Expanded Search
Genes match for BC030267   Similar terms to BC030267

   ATP13A2   (FLJ26510;HSA9947;KRPPD;PARK9;)


|<<     <<      >>     >>|   total pages:0
SKU   Category   Vector   Tag   Description   $ Price   Availability  
  SC126218     Human Clone pCMV6-XL5 No Tags ATP13A2 (untagged)-Human ATPase type 13A2, mRNA (cDNA clone MGC:40082 IMAGE:5240813), complete cds (10ug) 185 In Stock
SKU   Category   Vector   Description   $ Price   Availability  
  TF307223     Human shRNA pRFP-C-RS ATP13A2 - Human, 4 unique 29mer shRNA constructs in retroviral RFP vector 650 7-9 Days
  TL307223     Human shRNA pGFP-C-shLenti ATP13A2 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector 750 7-9 Days
  TR307223     Human shRNA pRS ATP13A2 - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector 498 In Stock
  TG307223     Human shRNA pGFP-V-RS ATP13A2 - Human, 4 unique 29mer shRNA constructs in retroviral GFP vector 498 In Stock
  SR308247     Human siRNA ATP13A2 (Human) - 3 unique 27mer siRNA duplexes - 2 nmol each 300 In Stock
  TL512485     Mouse shRNA pGFP-C-shLenti ATP13A2 - Mouse, 4 unique 29mer shRNA constructs in lentiviral GFP vector 750 7-9 Days
SKU   Category   Description   $ Price   Availability  
  KN215270     knockout ATP13A2 - gene knockout kit via CRISPR 1200 4 wks
Inc 5000 Healthcare Company Copyright © 2014 OriGene Technologies, Inc. All Rights Reserved. Legal Notices.
9620 Medical Center Dr., Suite 200, Rockville, MD 20850 • 1.888.267.4436

Reproduction of any materials from this website is strictly forbidden without permission.

All Products by: Title | Price | Category | Popularity | Best Sellers Topselling Products by: Title | Price | Category | Popularity | Favorites
Popular Categories: Popularity | Our Choices | All-Round Favorites | Title Topselling Categories: Popularity | Our Choices | All-Round Favorites | Title